Low Volumes For CME Make It Less Appealing, But Deutsche Bank Can't Make Up Mind

The CME Group (CME) reported May volumes today that showed weak growth: 4% year-over-year. While this tepid increase was expected, Deutsche cut its target price anyway.

CME is currently trading down below $400 after receiving a $1 billion settlement, regarding trading rights, from the Chicago Board Options Exchange. Yet Deutsche’s target price of $600 coupled with a HOLD rating looked to be about 6 months behind the times. Our guess is they were looking for any reason to lower the target.

The target now sits at $525, but, strangely, Deutsche stubbornly maintains its HOLD because they are taking “a more negative view on volumes”.

30%+ upside and a HOLD rating? Is this a case of wanting to have cake and eat it, too?


NOW WATCH: Money & Markets videos

Want to read a more in-depth view on the trends influencing Australian business and the global economy? BI / Research is designed to help executives and industry leaders understand the major challenges and opportunities for industry, technology, strategy and the economy in the future. Sign up for free at research.businessinsider.com.au.

Tagged In